CW July 2004
Volume 13Issue Number 7 July 2004 ISSN 10593802 Anticancer Agent Built from Anti-inflammatory DrugResearchers have used a recently developed anti-inflammatory drug as a starting point to construct a possible new, targeted anti-cancer agent. The new agent (OSU-03012) works by triggering cancer cells to self-destruct and is now undergoing laboratory testing by the National Cancer Institute?s (NCI) Rapid Access to Intervention Development (RAID) program.
Go to Previous Page Go to Next Page Source & Additional Reading C.-S. Chen, Cancer Research, June 15, 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
